489. Stability of Avian Influenza A(H5N1) Virus in Milk from Infected Cows and Virus-Spiked Milk.
作者: Lizheng Guan.;David Pattinson.;Amie J Eisfeld.;Tong Wang.;Peter J Halfmann.;Gabriele Neumann.;Tera R Barnhardt.;Alexis C Thompson.;Amy K Swinford.;Kiril M Dimitrov.;Keith Poulsen.;Yoshihiro Kawaoka.
来源: N Engl J Med. 2025年393卷22期2271-2273页 495. Trial of Pegcetacoplan in C3 Glomerulopathy and Immune-Complex MPGN.
作者: Fadi Fakhouri.;Andrew S Bomback.;Gema Ariceta.;Yahsou Delmas.;Bradley P Dixon.;Daniel P Gale.;Larry A Greenbaum.;Seung Hyeok Han.;Nicole Isbel.;Moglie Le Quintrec.;Christoph Licht.;Antonio Mastrangelo.;Masashi Mizuno.;Maria Izabel Neves de Holanda.;Matthew C Pickering.;Giuseppe Remuzzi.;Nicole Van De Kar.;Marina Vivarelli.;Patrick D Walker.;Dean Wallace.;Daniel Zecher.;Cedric Francois.;Pascal Deschatelets.;Li Li.;Zhongshen Wang.;Lydia Abad-Franch.;Nils Kinnman.;Luis López-Lázaro.;Johan Szamosi.;Carla M Nester.; .
来源: N Engl J Med. 2025年393卷22期2210-2220页
C3 glomerulopathy and primary immune-complex membranoproliferative glomerulonephritis (MPGN) generally result in glomerular C3 deposition and irreversible kidney damage. The efficacy and safety of pegcetacoplan, a C3 and C3b inhibitor, in persons with C3 glomerulopathy or primary immune-complex MPGN are unclear.
|